First Turn Management, LLC

Position in ERAS — Erasca, Inc.

CIK 1993440 DEL MAR, CA

Position in ERAS

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$14,038,399

New position

Shares Held

867,639

first reported quarter

Ownership

0.279%

of shares outstanding

% of Portfolio

1.57%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2026

1 quarter on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

First Turn Management, LLC holds $816,783,749 across 31 Biotechnology names. ERAS ranks #27 (1.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABVX	Abivax S.A.	465,869	$51,874,513
2	BBIO	BridgeBio Pharma, Inc.	695,718	$51,664,018
3	XENE	Xenon Pharmaceuticals Inc.	786,844	$45,754,978
4	RVMD	Revolution Medicines, Inc.	468,376	$45,549,566
5	APGE	Apogee Therapeutics, Inc.	513,770	$43,244,020
6	INSM	INSMED Inc	248,475	$40,630,632
7	NUVL	Nuvalent, Inc.	370,344	$37,941,742
8	MIRM	Mirum Pharmaceuticals, Inc.	400,464	$36,994,864

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$14,038,399	867,639	—	Shares	Sole	2026-05-15
No filing history on record for this holder in this stock.